GASTROINTESTINAL CANCER SCREENING
The foundation of your cancer screening journey
Gastrointestinal cancer screening is an endoscopy service using modern technology and AI to detect digestive-tract lesions and diseases early, from as small as 1mm. It offers several options (gastroscopy, colonoscopy, dual endoscopy) to suit each need, performed under gentle sedation and to Korean standards.
Gastrointestinal cancer screening
| No. | Service | Purpose | Male | Female |
|---|---|---|---|---|
| Examination list | ||||
| 1 | Gastrointestinal internal medicine consultation | Reviews medical history and clinical examination combined with endoscopy and other paraclinical results to conclude and advise on health. | ||
| 2 | Height, weight | Basic physique assessment. | ||
| 3 | Body Mass Index (BMI) | Body composition analysis (fat, muscle, water). | ||
| 4 | Blood pressure | Early detection and monitoring of cardiovascular conditions, especially hypertension or hypotension. | ||
| 5 | AI-assisted ECG | Identifies very subtle changes in heart waveforms: myocardial ischemia, arrhythmia, ventricular hypertrophy, heart-failure risk, aortic valve abnormalities...; 91-92% accuracy with near-99% risk exclusion. | ||
| 6 | AFP test (Alpha Fetoprotein) | Liver cancer marker. | ||
| 7 | CA 19-9 test (Carbohydrate Antigen 19-9) | Pancreatic cancer marker. | ||
| 8 | CEA test | Colorectal cancer marker. | ||
| 9 | Complete peripheral blood cell analysis (28 parameters) | Checks white cells, red cells, platelets..., assesses anemia and some blood disorders. | ||
| 10 | Urinalysis (11 parameters) | Detects urinary abnormalities to diagnose glomerular, urinary tract, liver, biliary and metabolic conditions... | ||
| 11 | PT - APTT - TT | Assesses hemostasis and clotting time. | ||
| 12 | ALT (GPT) | Assesses hepatocyte damage. | ||
| 13 | AST (GOT) | Assesses hepatocyte damage. | ||
| 14 | GGT (Gamma Glutamyl Transferase) | Assesses hepatocyte damage, biliary obstruction and monitors alcohol-related liver disease. | ||
| 15 | Urea | Assesses kidney function. | ||
| 16 | Creatinine | Assesses kidney function. | ||
| 17 | HBsAg (automated) | Detects hepatitis B infection. | ||
| 18 | HBsAb/Anti-HBs quantitative | Quantifies hepatitis B antibodies. | ||
| 19 | HCV Ab (automated) | Screens for hepatitis C infection. | ||
| 20 | Amylase | Diagnoses pancreatic conditions such as acute/chronic pancreatitis. | ||
| 21 | Lipase | Diagnoses pancreatic conditions. | ||
| 22 | Electrolytes (Na, K, Cl) | Measures serum Na, K, Cl to support diagnosis and monitoring of electrolyte disorders and some cardiovascular conditions. | ||
| 23 | Gastric H. pylori test | Detects H. pylori, a leading cause of stomach cancer. | ||
| 24 | HbA1c | Reflects average blood glucose over 2-3 months; confirms diagnosis and monitors diabetes treatment. | ||
| 25 | Glucose | Diagnoses glucose intolerance and diabetes. | ||
| 26 | Total cholesterol | Assesses blood lipid disorders. | ||
| 27 | Triglycerides | Assesses lipid disorders and screens for cardiovascular risk, atherosclerosis, myocardial infarction, stroke and pancreatitis. | ||
| 28 | HDL-C | Assesses blood lipid disorders. | ||
| 29 | LDL-C | Assesses blood lipid disorders. | ||
| 30 | Chest X-ray (PA) | Detects lung/pleural conditions (TB, lung tumors, pneumonia, pleural effusion/pneumothorax...); detects cardiomegaly suggesting heart failure. | ||
| 31 | Abdominal ultrasound (liver & biliary, pancreas, spleen, kidneys, bladder) | Examines and evaluates abdominal organ lesions; detects ovarian tumors, uterine fibroids and other gynecological conditions. | ||
| 32 | Anesthesia fee | Sedated endoscopy reduces anxiety and discomfort, supporting a safe and comfortable procedure. | ||
| 33 | Gastroscopy - colonoscopy | Direct surface observation to detect lesions such as ulcers, polyps, cancer, pre-cancer and fungal infections in the esophagus, stomach and colon. | ||
| 34 | AI gastrointestinal cancer screening solution (WAYCEN - WAYMED endo) | Detects and delineates micro-lesions from 1mm during endoscopy; provides comprehensive lesion analysis and risk classification, supporting early detection of pre-cancerous and cancerous lesions of the esophagus, stomach and colon. | ||
| Package price | ||||
| Package price (VND) | 9.500.000 đ | 9.500.000 đ | ||
| 30% discount | 6.650.000 đ | 6.650.000 đ | ||
Why GASTROINTESTINAL CANCER SCREENING is a trusted choice
Comprehensive screening in a single visit
Esophageal – gastric – colon endoscopy screens the entire digestive tract in one examination.
Advanced AI technology
Automatically detects and delineates micro-lesions from 1mm, minimizing missed lesions.
Painless sedated endoscopy
Sedated endoscopy reduces anxiety and discomfort for a gentle, painless experience.
Experienced Korean doctors
Experienced Korean physicians directly accompany the endoscopy process.
Strict infection control
A rigorous infection-control process ensures maximum safety for patients.
Korean-standard endoscopy process
Performed to Korean-standard endoscopy protocols; early detection raises the 5-year survival rate to over 90%.